key: cord-0873776-ep09rfnl
authors: Garg, Pankaj Kumar; Kaul, Pallvi; Choudhary, Deepti; Singh, Mahendra Pal; Tiwari, Ajeet Ramamani
title: Cancer surgery in the era of COVID‐19 pandemic: Changing dynamics
date: 2020-08-05
journal: J Surg Oncol
DOI: 10.1002/jso.26156
sha: a652e393c0453e151a0d4976eaadc965bb7f2bc8
doc_id: 873776
cord_uid: ep09rfnl

nan

Another study to assess the impact of the COVID-19 pandemic due to delays in diagnosis based on data for 32 583 patients with breast cancer, the authors estimated a 7.9% to 9.6% increase in the number of additional deaths compared to prepandemic figures. 4 Undeniably, surgery for breast cancer brings the most significant benefits for patients, especially in the curative setting leading to significant gains in survival. 5 Though the many initial guidelines prohibited performing surgery for breast cancer, it was soon realized that surgery cannot be postponed indefinitely. 6 Patients with breast cancer who have completed neoadjuvant chemotherapy or have salvageable progression on chemotherapy or patients with malignant breast sarcomas cannot be denied surgery for long as we grdually learn to coexist with COVID-19. 7, 8 With the COVID-19 pandemic still on run, many modifications are being made in the patient management strategies in the hospital so as to minimize the effect of COVID-19 on the perioperative outcomes. 

Discordance of COVID-19 guidelines for patients with cancer: a systematic review

Time to surgery and breast cancer survival in the United States

Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

ESMO management and treatment adapted recommendations in the COVID-19 era: breast cancer

GEICAM guidelines for the management of patients with breast cancer during the COVID-19 pandemic in Spain

Cancer surgery scheduling during and after the COVID-19 first wave: the MD Anderson cancer center experience

A practical approach to the management of breast cancer in the COVID-19 era and beyond

Ajeet Ramamani Tiwari MCh 1